China Life Insurance (Overseas) Company Limited (CHILOV)
Hong Kong / Insurance
Active
Issuer Summary
China Life Insurance (Overseas) Company Limited is the sole wholly owned overseas subsidiary of China Life Insurance (Group) Company and is a high-quality insurance credit supported by its Hong Kong and Macau life insurance franchise, A-range ratings, and unaudited company assets of HKD452.8bn as of end-December 2025 in the official profile. However, the 2023 USD2.0bn subordinated capital bonds mainly referenced under CHILOV are subordinated to policyholders and unsubordinated creditors and involve regulatory approval, uncertainty around the 2028 call, and limited remedies. The direction of issuer credit is more stable than improving, but detailed 2023-2025 financials, the latest RBC, detailed rating reports, and bond spreads have not been verified. These need to be reviewed for individual security analysis.
China Life Overseas’ current issuer credit strength can be assessed as a high-quality Hong Kong and Macau life insurance credit consistent with A-range ratings. The direction is more stable than improving, because detailed audited financials for 2023-2025 and the latest RBC have not been verified. Based on parental support expectations, unaudited company assets of HKD452.8bn as of end-December 2025 in the official profile, the Hong Kong and Macau franchise, and the 244% solvency ratio as of 2022, the likelihood of a sharp near-term decline in issuer credit appears low at present. However, the market price, call expectations, and recovery ranking of the subordinated capital bonds could deteriorate faster than issuer credit.
The most important supports for credit strength are the strategic importance of China Life Overseas as the wholly owned overseas subsidiary of China Life Group and its insurance franchise in Hong Kong and Macau. The scale of the parent, the brand of a state-owned financial group, A-range ratings, and a long operating history in the Hong Kong and Macau markets support policyholder confidence and access to capital markets. The 2025 IA statistics showing the presence of China Life in annualised premiums for Hong Kong direct individual new business also provide supporting evidence for the business base of the relevant Hong Kong insurance operation.
At the same time, the key constraint on the credit view is thin information. The 2025 official profile shows total assets and combined revenue, but it does not provide investment assets, insurance liabilities, comprehensive income, RBC, product-level profit, surrender rates, ALM, liquidity, or the capital recognition of the subordinated bonds. In the audited 2020-2022 data, gross premiums declined, net investment income fell sharply in 2022, and comprehensive income turned negative. This indicates that market and ALM sensitivity should not be underestimated for this insurer.
Issuer Reports
Current public reports for this issuer.